Cell-Free Compositions ATP Regeneration, Biocheminsights Inc
Summary
The European Patent Office published patent application EP3924471A1 for cell-free compositions for ATP regeneration and uses thereof, filed by Biocheminsights Inc. The named inventors are William ARMIGER and David DODDS. The application covers multiple IPC classifications including C12N 9/00, C12P 19/26, C12P 19/30, C12P 21/00, and is designated across 31 European patent convention states.
About this source
GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 53 changes logged to date.
What changed
The European Patent Office published patent application EP3924471A1 titled 'Cell-Free Compositions for ATP Regeneration and Uses Thereof' filed by Biocheminsights Inc. The application names William ARMIGER and David DODDS as inventors and covers cell-free compositions for ATP regeneration across multiple International Patent Classification codes including oxidoreductases (C12N 9/02), lyases (C12N 9/06), nucleic acid processes (C12P 19/26-36), and peptide processes (C12P 21/00). The patent is designated across 31 European patent convention contracting states.
Biocheminsights Inc now holds a published European patent application for ATP regeneration compositions, which may have implications for competitors developing similar cell-free biochemical systems. Third parties should review the application's claims upon publication in the EPO Register to assess potential freedom-to-operate concerns in European markets.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CELL-FREE COMPOSITIONS FOR ATP REGENERATION AND USES THEREOF
Publication EP3924471A1 Kind: A1 Apr 15, 2026
Applicants
Biocheminsights Inc.
Inventors
ARMIGER, William, DODDS, David
IPC Classifications
C12N 9/02 20060101AFI20221117BHEP C12N 9/06 20060101ALI20221117BHEP C12N 15/64 20060101ALI20221117BHEP C12N 15/88 20060101ALI20221117BHEP C12N 9/00 20060101ALI20221117BHEP C12P 19/26 20060101ALI20221117BHEP C12P 19/30 20060101ALI20221117BHEP C12P 19/34 20060101ALI20221117BHEP C12P 19/36 20060101ALI20221117BHEP C12P 21/00 20060101ALI20221117BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.